ACC SFBA Life Sciences Conference 2026
by Association of Corporate Counsel San Francisco Bay Area Chapter (ACC-SFBA)
The ACC SFBA Life Sciences Conference 2026 is an annual event organized by the Association of Corporate Counsel San Francisco Bay Area Chapter (ACC-SFBA). This virtual conference, scheduled for March 10-12, 2026, brings together legal professionals and industry experts to discuss current trends and challenges in the life sciences sector.
Key topics at the conference include legal ethics in life sciences intellectual property, focusing on managing conflicts, confidentiality, and compliance. Notably, Finnegan partner Jeffrey Smyth will participate in a panel discussion addressing these critical issues.
The event offers attendees opportunities for professional development and networking with peers in the life sciences legal community. Participants can engage in interactive sessions and gain insights from experienced practitioners.
This conference is ideal for in-house counsel, legal professionals, and industry stakeholders involved in the life sciences sector, providing valuable knowledge and connections to navigate the evolving legal landscape.
Speakers(23)
Ali Muffenbier
Associate – Finance at Freshfields
Ali Muffenbier is an associate in the finance department at Freshfields.
Andrew T. Dufresne
Partner at Perkins Coie
Andrew T. Dufresne is a partner at Perkins Coie.
Arpita Bhattacharyya Ph.D.
Partner at Perkins Coie
Dr. Arpita Bhattacharyya is a partner at Perkins Coie.
Betsy Haanes
Senior Director IP at Altos Labs
Betsy Haanes is the Senior Director of Intellectual Property at Altos Labs.
Briana Barron
Vice President, Intellectual Property at Arcus Biosciences
Briana Barron serves as Vice President of Intellectual Property at Arcus Biosciences.
Catherine Maresh
Chief Legal Counsel at DeepSight Technology
Catherine Maresh is the Chief Legal Counsel at DeepSight Technology.
Deborah Winokur
Associate General Counsel at Cozen O'Connor
Deborah Winokur is Associate General Counsel at Cozen O'Connor.
Deirdre Finn
National Practice Leader, Executive Risk Solutions at Newfront
Deirdre Finn is the National Practice Leader for Executive Risk Solutions at Newfront.
Eb Bright
President & General Counsel at ExploraMed
Eb Bright serves as President and General Counsel at ExploraMed.
Eric Tausend
SVP, Senior Director & West Regional ERS Leader at Newfront
Eric Tausend serves as Senior Vice President and Senior Director, leading the West Regional Executive Risk Solutions at Newfront.
Frank Freeman
Counsel at Eli Lilly
Frank Freeman serves as Counsel at Eli Lilly.
Jake A. Silvers
Senior Associate at Freshfields
Jake A. Silvers is a senior associate at Freshfields.
Jeffrey D. Smyth
Partner at Finnegan
Jeffrey D. Smyth is a partner at Finnegan, specializing in intellectual property law.
Kevin Underhill
Partner at Shook Hardy
Kevin Underhill is a partner at Shook Hardy.
Kristen O. Riemenschneider
Partner at Freshfields
Kristen O. Riemenschneider is a partner at Freshfields.
Laurie Carr Mims
Managing Partner at Keker Van Nest & Peters
Laurie Carr Mims is the Managing Partner at Keker Van Nest & Peters.
Madeleine Tavcar
Senior Associate at Freshfields
Madeleine Tavcar is a senior associate at Freshfields.
Matthew A. Chivvis
Partner at Morrison Foerster
Matthew A. Chivvis is a partner at Morrison Foerster.
Sarah B. Johansen
Partner at Reed Smith
Sarah B. Johansen is a partner at Reed Smith.
Shane B. Kolding
Associate at Shook Hardy
Shane B. Kolding is an associate at Shook Hardy.
Siddharth Kishore Ph.D.
Business Development & Acquisitions at AbbVie
Dr. Siddharth Kishore works in Business Development and Acquisitions at AbbVie.
Stephen Brady
CEO at Tempest Therapeutics
Stephen Brady is the Chief Executive Officer of Tempest Therapeutics.
Steven J. Boranian
Partner at Reed Smith
Steven J. Boranian is a partner at Reed Smith.
Event Details
- Date
- March 10-12, 2026
- 3 days
- Location
- 🇺🇸 United States
- Audience
- In-house counsel, legal professionals, and industry stakeholders in the life sciences sector.